Flash FinanceUS
Pre-market S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Bruker (BRKR)

Bruker Q3 revenue up 1.6% to $874.0 million; GAAP loss from $174.5 million impairment

Mixed Impact 3 of 5 earnings

Bruker reported third-quarter 2026 revenue of $874.0 million, up 1.6% from a year earlier, and non-GAAP diluted EPS of $0.56, up 24.4%. GAAP results were a diluted loss of $(0.81) per share, driven by a $174.5 million goodwill impairment charge, and the company reconfirmed its FY26 organic revenue growth and non-GAAP EPS guidance of $2.10 to $2.15.

Key points

  • Q3-26 revenue $874.0 million, up 1.6% yoy; organic growth 0.7%
  • Q3-26 non-GAAP diluted EPS $0.56, up 24.4% from $0.45; GAAP diluted loss $(0.81) vs. $(0.41) a year earlier
  • Q3-26 GAAP operating loss $(91.0) million, including a $174.5 million goodwill impairment charge
  • FY26 non-GAAP EPS outlook of $2.10 to $2.15 reconfirmed; FY26 revenue guidance $3.52 to $3.56 billion

The filing

CompanyBruker (BRKR)
Form8-K, current report
Filed with the SECNov 4, 2026, 7:00 AM ET
Accession number0001193125-26-446176

Items reported: 2.02 Results of Operations

Read the filing on SEC.gov ↗

Written by AI on Nov 7, 2026, 11:17 PM ET, from this filing only.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.